1,847
Registered trials
679
Recruiting
1,077
Completed trials
503
Sponsors active
314
Research sites
Phase III:
740
Phase II/III:
76
Phase II:
407
Phase I/II:
97
Phase III/IV:
38
Phase IV:
157
Phase I:
98
Phase I (Other):
141
Phase I (FiH):
85
Other:
9
Other:
1
Oversight events in trials active here:
111 serious breaches
467 temporary halts
33 urgent safety measures
66 unexpected events
82 corrective measures
across 285 trials
View oversight register →
Top conditions
Non-small cell lung cancer
68
Crohn's disease
19
Non-small cell lung cancer metastatic
18
Prostate cancer metastatic
17
Diffuse large B-cell lymphoma
14
Colitis ulcerative
11
Colorectal cancer
11
Systemic lupus erythematosus
11
Amyotrophic lateral sclerosis
11
Pulmonary arterial hypertension
11
Endometrial cancer
10
Myasthenia gravis
9
Top sponsors
Novartis Pharma AG
70
AstraZeneca AB
61
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
55
Merck Sharp & Dohme LLC
55
Janssen - Cilag International
54
Amsterdam UMC
46
F. Hoffmann-La Roche AG
46
AbbVie Deutschland GmbH & Co. KG
42
Universitair Medisch Centrum Groningen
39
Amsterdam UMC Stichting
38
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
38
Boehringer Ingelheim International GmbH
37
Cities with most trials
All 116 cities →All trials — page 84
1,847 totalShowing 1,993–1,847 of 1,847 trials